FDA advisors back laserless hyperopia treatment
This article was originally published in Clinica
Executive Summary
A US FDA advisory panel has recommended that the agency approve a procedure for correcting hyperopia that uses radiofrequency (RF) energy rather than lasers to treat the condition.